Exploration of the Shared Gene Signatures and Molecular Mechanisms Between Systemic Lupus Erythematosus and Pulmonary Arterial Hypertension: Evidence From Transcriptome Data
Authors:
Open Access
- 15 July 2021
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 12, 658341
Abstract
Background: Systemic lupus erythematosus (SLE) is an autoimmune disease that can affect multiple systems. Pulmonary arterial hypertension (PAH) has a close linkage with SLE. However, the inter-relational mechanisms between them are still unclear. This article aimed to explore the shared gene signatures and potential molecular mechanisms in SLE and PAH.Methods: The microarray data of SLE and PAH in the Gene Expression Omnibus (GEO) database were downloaded. The Weighted Gene Co-Expression Network Analysis (WGCNA) was used to identify the co-expression modules related to SLE and PAH. The shared genes existing in the SLE and PAH were performed an enrichment analysis by ClueGO software, and their unique genes were also performed with biological processes analyses using the DAVID website. The results were validated in another cohort by differential gene analysis. Moreover, the common microRNAs (miRNAs) in SLE and PAH were obtained from the Human microRNA Disease Database (HMDD) and the target genes of whom were predicted through the miRTarbase. Finally, we constructed the common miRNAs–mRNAs network with the overlapped genes in target and shared genes. Results: Using WGCNA, four modules and one module were identified as the significant modules with SLE and PAH, respectively. A ClueGO enrichment analysis of shared genes reported that highly activated type I IFN response was a common feature in the pathophysiology of SLE and PAH. The results of differential analysis in another cohort were extremely similar to them. We also proposed a disease road model for the possible mechanism of PAH secondary to SLE according to the shared and unique gene signatures in SLE and PAH. The miRNA–mRNA network showed that hsa-miR-146a might regulate the shared IFN-induced genes, which might play an important role in PAH secondary to SLE.Conclusion: Our work firstly revealed the high IFN response in SLE patients might be a crucial susceptible factor for PAH and identified novel gene candidates that could be used as biomarkers or potential therapeutic targets.Keywords
Funding Information
- Henan Provincial Science and Technology Research Project
This publication has 50 references indexed in Scilit:
- Exploring Shared Pathogenesis of Alzheimer’s Disease and Type 2 Diabetes Mellitus via Co-expression Networks AnalysisCurrent Alzheimer Research, 2020
- Systemic Lupus ErythematosusAnnals of Internal Medicine, 2020
- Meta-analysis of blood genome-wide expression profiling studies in pulmonary arterial hypertensionAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2020
- Molecular genetic framework underlying pulmonary arterial hypertensionNature Reviews Cardiology, 2019
- Bioinformatic gene analysis for potential biomarkers and therapeutic targets of atrial fibrillation-related strokeJournal of Translational Medicine, 2019
- Pulmonary arterial hypertension in systemic lupus erythematosus based on a CSTAR‐PAH study: Baseline characteristics and risk factorsInternational Journal of Rheumatic Diseases, 2019
- Epidemiology and treatment of pulmonary arterial hypertensionNature Reviews Cardiology, 2017
- Clinical characteristics and survival of pulmonary arterial hypertension associated with three major connective tissue diseases: A cohort study in ChinaInternational Journal of Cardiology, 2017
- Serological biomarkers as risk factors of SLE-associated pulmonary arterial hypertension: a systematic review and meta-analysisLupus, 2017
- Arterial stiffness, antiphospholipid antibodies, and pulmonary arterial hypertension in systemic lupus erythematosusJournal of Cardiology, 2014